---
title: "State Tanning Bed Availability Linked to Higher Early-Onset Melanoma in Midwest and South"
id: "medrxiv-1-state-tanning-bed-availability-is-associated-with-early-onset-melanoma"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-state-tanning-bed-availability-is-associated-with-early-onset-melanoma"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1?rss=1"
published_at: "2026-08-24T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# State Tanning Bed Availability Linked to Higher Early-Onset Melanoma in Midwest and South
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-state-tanning-bed-availability-is-associated-with-early-onset-melanoma
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1?rss=1)
- **Published At:** 2026-08-24T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study tested whether state-level **tanning bed** availability is associated with **early-onset melanoma** incidence using population-based registry data from 2019–2023. - Researchers used National Program of Cancer Registries (NPCR) melanoma incidence data and categorized states into verified quintiles of tanning bed availability. - In the Midwest and Southern US, melanoma incidence rose across tanning-bed availability quintiles: 8.7 cases/100,000 in Quintile 1 to 14.8 cases/100,000 in Quintile 5. - The incidence rate ratio (IRR) comparing highest to lowest quintile in Midwest/South was 1.69 (95% CI = 1.65–1.74). - No association between tanning bed availability and early-onset melanoma incidence was observed in Northeast/West regions. - The association in Midwest/South held for non-Hispanic White males and females and was present in both metropolitan and non-metropolitan counties. - Authors conclude that policies reducing **tanning bed availability** in high-utilization regions may reduce **early-onset melanoma**; specific policy measures were not detailed in the source. - Data are publicly available from NPCR; supplementary material and code availability were referenced but details beyond that were not reported in the abstract. - The authors declared no competing interests and confirmed ethical approvals and participant consent procedures were followed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=XeIC_CApw.Nd760gSmYuFr_usLPgr1kpaIEKR9npiVg-1787604006.9190137-1.2.1.1-9rvZM08f5aGe0rBEU8VZEQLIleVkyEZVJb1jrx5GRsfgOp39OzDfJDnkE4.aisyC) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # State tanning bed availability is associated with early-onset Melanoma incidence in the Midwest and Southern United States Danielle Graffam, [ View ORCID Profile](http://orcid.org/0000-0002-0375-8090)Jason Semprini doi: https://doi.org/10.64898/2026.08.21.26361039 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Danielle Graffam Des Moines University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Danielle%2BGraffam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Graffam%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADanielle%2BGraffam%2B) Jason Semprini Des Moines University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jason%2BSemprini%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Semprini%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJason%2BSemprini%2B) * [ORCID record for Jason Semprini](http://orcid.org/0000-0002-0375-8090 "Open in new tab") * For correspondence: jsemprini@dmu.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1284435/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1284435/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1284435/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1284435/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1284435/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1284435/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Despite known carcinogenic properties, indoor tanning remains popular among young adults and may contribute to early-onset melanoma. Our study aims to compare early-onset melanoma incidence by state availability of tanning beds. We analyzed population-based melanoma incidence data (2019-2023) from the National Program of Cancer Registries and calculated Incidence Rate Ratios (IRR) using verified state-level quintiles of tanning bed availability. Overall, in the Midwest/South regions, melanoma incidence increased with greater tanning-bed availability, from 8.7 cases per 100,000 population in Quintile 1 to 14.8 cases per 100,000 population in Quintile 5 (IRR = 1.69; CI = 1.65-1.74). No such relationship was found in the Northeast/West regions. In conclusion, we found that in Southern and Midwest states, increased availability of tanning beds was associated with higher early-onset melanoma in non-Hispanic White males and females, in both metro and non-metro counties. Policies which reduce tanning bed availability in high utilization regions may have potential to reduce early-onset melanoma. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data is publicly available from NPCR. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.21.26358613v1 "The VPS35 p.A320V variant segregates with Parkinson's disease in a pesticide-exposed family")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.21.26361022v1 "The Role of Bone Marrow Microenvironment in Osteogenesis Imperfecta: Evidence from Single-Cell RNA Sequencing") Posted August 24, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/24/2026.08.21.26361039.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/24/2026.08.21.26361039.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) State tanning bed availability is associated with early-onset Melanoma incidence in the Midwest and Southern United States Danielle Graffam, Jason Semprini medRxiv 2026.08.21.26361039; doi: https://doi.org/10.64898/2026.08.21.26361039 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26361039v1%26text%3DState%2520tanning%2520bed%2520availability%2520is%2520associated%2520with%2520early-onset%2520Melanoma%2520incidence%2520in%2520the%2520Midwest%2520and%2520Southern%2520United%2520States "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26361039v1%26t%3DState%2520tanning%2520bed%2520availability%2520is%2520associated%2520with%2520early-onset%2520Melanoma%2520incidence%2520in%2520the%2520Midwest%2520and%2520Southern%2520United%2520States "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26361039v1%26title%3DState%2520tanning%2520bed%2520availability%2520is%2520associated%2520with%2520early-onset%2520Melanoma%2520incidence%2520in%2520the%2520Midwest%2520and%2520Southern%2520United%2520States%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26361039v1%26title%3DState%2520tanning%2520bed%2520availability%2520is%2520associated%2520with%2520early-onset%2520Melanoma%2520incidence%2520in%2520the%2520Midwest%2520and%2520Southern%2520United%2520States "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.21.26361039) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.21.26361039v1&count=horizontal&via=&text=State%20tanning%20bed%20availability%20is%20associated%20with%20early-onset%20Melanoma%20incidence%20in%20the%20Midwest%20and%20Southern%20United%20States&counturl=www.medrxiv.org/content/10.64898/2026.08.21.26361039v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (611) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (891) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (324) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4742) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (405) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (638) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1609) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15779) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1193) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6948) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (724) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1049) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4948) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1419) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1729) * [Hematology](https://www.medrxiv.org/collection/hematology) (576) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1326) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16223) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1156) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (658) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (717) * [Neurology](https://www.medrxiv.org/collection/neurology) (7139) * [Nursing](https://www.medrxiv.org/collection/nursing) (359) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1070) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1221) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (996) * [Oncology](https://www.medrxiv.org/collection/oncology) (3561) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1031) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (387) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (443) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (464) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (138) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1767) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (730) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (757) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5804) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9651) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2366) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1421) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1235) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (762) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (758) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (300) * [Urology](https://www.medrxiv.org/collection/urology) (285) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](https://medrxiv.org/alerts). Sign In to Follow this Preprint Email * Email this Articleclose Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following [State tanning bed availability is associated with early-onset Melanoma incidence in the Midwest and Southern United States](https://www.medrxiv.org/content/10.64898/2026.08.21.26361039v1) Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Citation Toolsclose State tanning bed availability is associated with early-onset Melanoma incidence in the Midwest and Southern United States Danielle Graffam, Jason Semprini medRxiv 2026.08.21.26361039; doi: https://doi.org/10.64898/2026.08.21.26361039 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what do
## Related Clinical Research

- [Personalized mRNA vaccine plus pembrolizumab lowers melanoma recurrence in phase 3 trial](https://medichelpline.com/clinical-feed/medical-news-today-0-novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial.md)
- [Arginine supplements and immune recognition: mouse study links arginine to improved cancer and vir](https://medichelpline.com/clinical-feed/medical-news-today-0-could-arginine-supplements-help-boost-immune-responses-to-cancer-viruses.md)
- [Explainable Ensemble AI for Melanoma Detection with Leakage-Free Internal Validation](https://medichelpline.com/clinical-feed/medrxiv-0-skin-cancer-classification-using-explainable-artificial-intelligence-with-an.md)
- [FDA approves first targeted pancreatic cancer drug; Trump administration strikes biotech drug-pric](https://medichelpline.com/clinical-feed/stat-news-2-stat-pharmalittle-we-re-reading-about-a-pancreatic-cancer-drug-approval-a-trump.md)
- [Moderna–Merck cancer vaccine and the role of the algorithm behind its mRNA design](https://medichelpline.com/clinical-feed/stat-news-1-stat-the-mystery-of-moderna-s-magic-algorithm.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.